Jennifer Lachey

Technik-/Wissenschafts-/F&E-Leiter bei KEROS THERAPEUTICS, INC.

51 Jahre

Health Technology

Consumer Services

Aktive Positionen von Jennifer Lachey

Unternehmen	Position	Beginn	Ende
KEROS THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.06.2019	-
KEROS THERAPEUTICS, INC.	Corporate Officer/Principal	01.07.2016	01.06.2019

Unternehmen	Position	Beginn	Ende
SERES THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	01.03.2015	01.07.2016
EMBER THERAPEUTICS, INC.	Corporate Officer/Principal	01.07.2012	01.01.2015
ACCELERON PHARMA INC.	Corporate Officer/Principal	01.01.2008	01.07.2012

Indiana University	Undergraduate Degree
University of Cincinnati (Ohio)	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Director/Board Member	1

Sektoral

Health Technology	5
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
KEROS THERAPEUTICS, INC.	Health Technology
SERES THERAPEUTICS, INC.	Health Technology
EMBER THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ.	Health Technology

Private Unternehmen

Health Technology